Kheng Hwa Ko Insider Profile
4 Followers
Kheng Hwa Ko, Director at iX Biopharma Ltd., holds 479.54K shares in iX Biopharma Ltd. (Ticker: SG:42C). Most recently, Kheng Hwa Ko Bought 18,444 shares of iX Biopharma Ltd. on Jul 25, 2016 for an estimated value of S$3.87K.
Kheng Hwa Ko's Trading History
| 42CiX Biopharma Ltd. | Jul 25, 2016 | Director | Informative Buy | 3.87K | S$227.78K | |||||||||||||||||||||||||||||||||||||||||||
SG:42C Insider Shares: 479.54K (7.51%)
| ||||||||||||||||||||||||||||||||||||||||||||||||
You May Also Like
Kheng Hwa Ko insider profile FAQ
What is the percentage of profitable transactions made by Kheng Hwa Ko?
The percentage of profitable transactions made by Kheng Hwa Ko is 33%.
What is the average return per transaction made by Kheng Hwa Ko?
The average return per transaction made by Kheng Hwa Ko is -7.80%.
What stocks does Kheng Hwa Ko hold?
Kheng Hwa Ko holds: SG:42C stocks.
What was Kheng Hwa Ko’s latest transaction?
Kheng Hwa Ko’s latest transaction was an Informative Buy of S$3.87K.
What was Kheng Hwa Ko's most profitable transaction?
Kheng Hwa Ko’s most profitable transaction was an Informative Buy of SG:42C stock on October 29, 2015. The return on the trade was 4.60%.
What is Kheng Hwa Ko's role in iX Biopharma Ltd.?
Kheng Hwa Ko's role in iX Biopharma Ltd. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
